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Abstract Objective." To evaluate 
the predicted mortality rate of on- 
cologic patients in the PICU using 
the PRISM score and factors that 
might influence short-term out- 
comes .  
Design: Retrospective study. 
Settincj." Pedriatic ICU in a univer- 
sity hospital. 
Patients and Methods: The medical 
charts of all oncologic patients ad- 
mitled to the PICU during the peri- 
od from January 1983 to December 
1992 were reviewed. 
Main Results." Over a period of 10 
years, 51 oncologic patients were 
admitted on 57 occasions to the 
PICU. The mortality was 32%. 
This is significantly higher than the 
overall mortality in the PICU (8%). 
Comparison of observed and pre- 
dicted mortality, derived from the 
PRISM score, using chi square 
goodness-of-fit tesls showed a sig- 
nificantly higher observed mortality 
(x2(5) - 20.1, P < 0.01). Patients 
admitted for circulatory failure had 
the highest mortality (47%), fol- 
lowed by those with respiratory 
failure due to tachypnea/cyanosis 
(36%), central nervous system de- 
terioration (27%), respiratory fail- 
ure due to airway obstruction 
(25%), and metabolic disorders 
(20%). Of the 31 patients who 
needed mechanical ventilation, 17 
died (55%), and when they needed 
inotropic support as well, the mor- 
tality increased to 69%. The mor- 
tality rose to 100% when the pa- 
tient was admitted with a septic 
shock, necessitating mechanical 
ventilation and inotropic support. 
The median PRISM score was 5 in 
the survivor group and 18.5 in the 
non-survivor group; this difference 
was found to be significant using 
the Wilcoxon test (P - 0.01). How- 
ever, some patients with high scores 
were found in the survivor group, as 
well as some with low scores in the 
non-survivor group. 
Com'lusion: The decision to treat 
oncologic patients in a PICU re- 
mains difllcult and has to be con- 
sidered on an individual basis. 
However, oncologic patients do be- 
nefit from admission to the PICU. 
Tlle PRISM score is not suitable for 
oncologic patients in the PICU, 
because it underestimates the ob- 
served mortality. Other factors like 
neutropenia, septic shock, the need 
for mechanical ventilation, and in- 
otropic support should be taken 
into consideration. 
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Introduction 
Children with a malignancy have a relatively good 
prognosis in comparison with adults. In pediatric 
oncology, an overall 5-year survival rate of 66.8% has 
been reached [-1]. However, treatment of oncologic 
patients is very intensive and life-threatening complica- 
tions can occur. These complications, uch as respira- 
tory failure, circulatory failure, neutropenia, nd septic 
shock, may require treatment in a pediatric intensive 
care unit (PICU). The decision to admit oncologic 
patients to the PICU may be difficult, not because the 
outcome from their underlying disease is uncertain, but 
because the results of PICU admission and therapy in 
terms of futile suffering, efforts, and costs might be 
discouraging for patients, parents, and doctors. Knowl- 
edge of prognostic factors and outcomes of oncologic 
patients in the PICU is essential. To assess everity of 
illness and to calculate the mortality risk, scoring sys- 
tems can be used. We used the pediatric risk score for 
mortality (PRISM) to assess the severity of illness at 
admission. This score matches the observed mortality 
very well in non-oncologic patients [2]. Oncologic pa- 
tients admitted to the PICU have a mortality rate far 
above the overall mortality [3, 4, 5]. One might specu- 
late that the PRISM score in its unadapted form is not 
as suitable for oncologic as for non-oncologic patients. 
This study was undertaken: (1) to evaluate the out- 
come of oncologic patients in the PICU, (2) to evaluate 
the PRISM score in oncologic patients, and (3) to 
identify other factors that might influence short-term 
outcomes. 
Patients and methods 
The Sophia Children's Hospital in Rotterdam is one of the four 
pediatric oncology centers in the Netherlands. About 65 new on- 
cologic patients are admitted each year. The medical charts of all 
oncologic patients admitted to the PICU over a 10-year period 
(January 1983-December 1992), were reviewed. The admission 
policy for oncologic patients is the same as for other patients. 
However, in oncologic patients who are clearly in the final stage of 
their oncologic disease, a "do not resuscitate" policy is often used 
and therefore these patients are not admitted to the PICU when they 
need vital support. Therefore, this group was not included in this 
study. When a patient was admitted to the PICU more than once, 
all admissions were taken into account. Patients admitted for 
postoperative surveillance were also excluded from this study. 
The information retrieved from the medical charts included: age, 
sex, oncologic diagnosis, date of diagnosis, chemo- or radiotherapy 
in previous treatment regimens, operation before admission, cause of 
admission, duration of stay, neutropenia, infection, septic shock, 
respiratory infection, respiratory failure, mechanical ventilation, 
inotropic support, survival, and eventual cause of death. Table 1 
shows the number of patients admitted according to cause of admis- 
sion. 
To diagnose septic shock, at least four of the following criteria 
had to be met [6]: (1) body temperature <35.5~ or >38.9~ 
(2) hypotension (systolic pressure <5th percentile for age), 
(3) tachypnea ( > 95th percentile) or hypocapnia (P,CO2 < 4.3 kPa), 
(4) tachycardia (heart rate >95th percentile), (5) abnormal white 
blood-cell count (< 3.5"109/1 or > 15.0" 109/1) or a severe shift to the 
left, (6) thrombocytopenia (<100"109/1), (7) surgical or invasive 
procedure performed uring the previous 48 h or the presence of an 
obvious primary septical site. 
To diagnose respiratory infection, not only an abnormality on 
the chest radiograph ad to be found, but two of the following items 
as well: (1) a positive sputum culture, (2) a body temperature 
>38.5 ~ or (3) an elevated ESR or CRP. 
The diagnosis of respiratory failure was made, when the follow- 
ing criteria were found [71: (1) a P,O2 < 10 kPa with an FiO2 >0.5, 
(2) diffuse bilateral pulmonary infiltrates on chest radiograph, 
(3) exclusion of cardiogenic pulmonary edema clinically or with 
pulmonary artery catheterization (PAOP < 2.9 kPa). 
A patient was considered neutropenic if a neutrophil count of 
< 1.0"109/1 was found. We divided this group into subgroups, one 
group with neutrophil counts of <1.0 and the other with 
< 0.1"109/1. 
In order to assess objectively the severity of illness the PRISM 
score, a scoring system using 14 physiological variables, was applied. 
The PRISM score was measured on the day of admission and the 
mortality risk was calculated using the algorithm of Pollack et al. 
[2]. To calculate the mortality risk of a group, the mean of all 
individual mortality risks was used. 
PICU mortality was defined as death in the PICU. Whenever a
"not to be resuscitated" (NTBR) policy was used in the PICU it was 
on the basis of the current disease, not on the basis of the oncologic 
disease. These patients died in the PICU (PICU mortality). 
To compare predicted and observed mortality, the chi square 
goodness-of-fit test was used. The Wilcoxon test was used to com- 
pare PRISM scores in the survivor and non-survivor groups. 
Table 1 PRISM score, predicted 
and observed mortality 
according to causes 
of admission 
Cause of Number of Inotropic Septic Median Mortality Mortality 
admission patients support shock PRISM predicted observed 
Respiratory failure 
Airway obstruction 4 1 (25%) 0 (0%) 10.5 (2 55) 29% 25% 
Tachypnea/cyanosis 14 7 (50%) 1 (7%) 9.0 (~26) 12% 36% 
Neurological 15 2 (13%) 0 (0%) 10.0 (0M2) 19% 27% 
Metabolic 5 0 (0%) 2 (40%) 12.0 (5 14) 7% 20% 
Circulatory failure 15 8 (53%) 5 (33%) 7.0 (2-26) 10% 47% 
Miscellaneous 4 0 (0%) 0 (0%) 6.0 (4 9) 2% 0% 
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Results 
A total of 51 patients were admitted on 57 occasions. 
The group consisted of 31 boys and 26 girls, the median 
age was 6.9 years (range 0 17). The mortality of this 
group of patients was 32% (18/57). The overall mortal- 
ity in the PICU evaluated over the study period was 
8 %. The number of patients with inotropic support and 
septic shock, the median PRISM scores and the pre- 
dicted and observed mortality rate of each admission 
category are listed in Table 1. 
Compared to the observed mortality, the predicted 
mortality, based on the PRISM score (13%), is sig- 
nificantly lower (22(5)  m 20.1,P <0.01). Table 2 com- 
pares the survivor and non-survivor groups and 
shows significantly differences between the median 
PRISM scores: 18.5 (6-55) for the non-survivor group 
and 5 (0 17) for the survivor group (P <0.01). How- 
ever, very low scores can be found in the non-survivor 
group, and high scores can be found in the survivor 
group. Mortality rate by PRISM score is shown in 
Table 3. Except for the group with PRISM score 0 5, 
the predicted mortality is much lower than the ob- 
served mortality. 
Important factors related to mortality are septic 
shock, neutropenia, the need for mechanical ventilation 
and/or inotropic support (Table 1). In the group of 
respiratory failure (n = 18) 6 patients died. All six re- 
quired mechanical ventilation and 4 needed inotropic 
support as well. In the circulatory failure group 
(n = 15) 6 of the 7 patients who died required mechan- 
ical ventilation and inotropic supporL and 3 of them 
suffered from a septic shock as well. Of the patients 
admitted for neurological causes (n = 15) 4 died. Two 
of these patients needed mechanical ventilation and 
two needed inotropic support and mechanical ventila- 
tion. The non-surviving patient in the metabolic group, 
admitted for serious electrolyte disturbances leading to 
rhythm disturbances, was also suffering from septic 
shock and required mechanical ventilation. 
Table 2 Diilerences between the survivor and non-survivor g oups 
Non-survivors Survivors Morlality 
n - 18 n 39 
Artilicial ventilation 17 (94%) 14 (36%) 17/31 (55%) 
lnotropic support 11 (61%) 7 (18%) 11/18 (61%) 
Ventilation and 11 (61%) 5 (13%) 11/16 (69%) 
inotropes 
Ventilation, inotropes 3 (17%) 0 (0%) 3/3 (100%) 
and septic shock 
Neutropenia 7 (39%) 8 (21%) 7/15 (47%) 
Of the 31 patients who were mechanically ven- 
tilated 55% of them died; 16 patients received both 
mechanical ventilation and inotropic support and 69% 
of them died. Three patients were in septic shock and 
needed mechanical ventilation and inotropic support; 
their mortality was 100%. Of the 15 neutropenic 
patients 7 died (47%). Eight neutropenic patients 
needed mechanical ventilation and 7 (88%) of them 
died (Table 2). 
The median duration of stay in the PICU was not 
significantly different for survivors; 5 (1-59) days, as 
compared to non-survivors; 2 (1-19) days. 
Discussion 
This study was undertaken to investigate the outcome 
and predictability of outcome of oncologic patients in 
the PICU. In general patients are admitted when inva- 
sive monitoring is required or when they need support 
of the vital functions. We found a 32% mortality rate in 
this group of oncologic patients, which is much higher 
than the overall mortality rate (8%) in the PICU. In the 
literature on oncologic patients, PICU mortalities of 
51% [3], 48% [4] and 49% [-5] were found. 
Major differences in mortality rates are found when 
the groups are subdivided according to admission cri- 
teria. The 15 patients admitted for circulatory failure 
had the worst outcome with a mortality rate of 47%. 
Sivan et al. [3] also found a mortality rate of 47% in 
this group, while Butt et al. [4] found a much higher 
mortality rate of 75%. 
The PICU mortality in the group of patients with 
respiratory failure due to tachypnea/cyanosis was 36%. 
In the other studies, mortality rates of 75% [4], 73% 
[5] and 60% [3] were found. The discrepancy increases 
in the group with impaired ventilation due to tumor- 
mass effects: in this group mortalities of 0% [4], 20% 
[5] and 75% [3] were reported. In our group of 4 pa- 
tients, 1 patient died (25%). 
Another large difference is found in the group of 
patients admitted with primarily neurological disease. 
We found a mortality of 27% (4/15), while others found 
a 38% [-5], 48% [-4] and 90% [3] mortality. Three of 
the 4 non-survivors in this group died on the day that 
the diagnosis of leukemia was made. All 3 suffered from 
cerebral bleeding and died of cerebral compression 
resulting in brain death. 
In all of our subgroups and in all of the studies on 
this subject, the mortality of ventilated patients is high- 
er than that of non-ventilated patients (xX(5) = 14.2, 
P <0.05). Twenty-six children (46%) did not require 
mechanical ventilation and 1 (3%) of them died. Of our 
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31 ventilated patients, 17 (55%) died (Table 2). How- 
ever, part of the ventilated patients required inotropic 
support as well or were in a septic shock. There were 12 
patients who needed mechanical ventilation without 
inotropic support and who were not in shock. Of these 
12 patients 4 died (33%). Mortality rises to 62% when 
there is a need for inotropic support and mechanical 
ventilation and finally a 100% mortality is found when 
the patients also suffered from a septic shock. 
We, as in the other studies, found a very high 
mortality in the group of patients uffering from a sep- 
tic shock: five out of eight patients died (63%). Two of 
these non-surviving patients were not neutropenic but 
they did need mechanical ventilation. The three survi- 
vors were neutropenic but did not need artificial venti- 
lation or inotropic support. 
Fifteen patients were neutropenic and 7 of them 
died (47%). Sivan et al. [3] concluded that the severity 
of the neutropenia does affect the prognosis. In our 
study, seven patients had a neutrophil count of 
< 0.1.109/1,  four  of  whom died in the PICU, while eight 
patients had a neutrophil count of 0.1-1.0,109/1, three 
of them died in the PICU. Although we suspect he 
severity of neutropenia to be an important prognostic 
factor, we cannot draw that conclusion because the 
groups are too small. Another factor that could affect 
outcome is whether or not there is a rise in the neu- 
trophil count. In none of the non-survivors was a rise in 
the count seen. However, after one week the neutrophil 
count had risen in only three of the eight survivors. 
Again, no conclusion can be drawn from these small 
numbers. 
The PRISM score is used to asses the severity of 
illness and to help predict the short-term outcome in 
groups of patients. However, the PRISM score cannot 
be used to predict mortality of an individual patient, 
because there is an overlap in the scores of survivors 
and those of non-survivors. Our results show that the 
PRISM score is not useful in predicting mortality for 
oncologic patients. Although the observed mortality 
rises with higher PRISM scores, we found that the 
predicted mortality was significantly lower than the 
observed mortality (x2(5)= 20.1, P <0.01). Dividing 
the group of patients into subgroups according to their 
PRISM scores, this difference was seen in all groups 
except in the groups with a PRISM score of ~5 and 
> 25 (Table 3). We found that the predicted mortality 
was too low in the groups where for admission was 
metabolic, cardiogenic, or respiratory failure due to 
tachypnea/cyanosis (Table 1). 
The mortality rate of the oncologic patients in the 
PICU in our study (32%) is much lower than that 
found in the other studies, which were all approxi- 
Table 3 Mortality rate by PRISM score 
PRISM score Number of Predicted Observed 
patients mortality mortality 
0 5 20 1% 0% 
6 10 14 3% 36% 
10 15 8 8% 25% 
16 20 7 17% 57% 
21 25 3 42% 100% 
> 25 5 75% 80% 
mately 50%. Because the overall PICU mortality is the 
same in all studies (9% E4], 8% [3], 8% this study), this 
cannot be explained by differences in quality of care in 
the PICU's. One possible xplanation could be that our 
patients were not as severely ill as the patients in the 
other studies. However, the PRISM scores in our series 
(0-55, median 9), do not differ from the physiologic 
stability index (PSI) scores in the study of Sivan et al. 
[3] (1-31, median 11.4). Because the PRISM score is 
derived from the PSI score, these scores are compara- 
ble to one another. Therefore this excludes the possibil- 
ity that the patients in our study were less severely ill 
than those in the Sivan et al. study. Heney et al. [5] 
used the APACHE-II score and in the study of Butt et 
al. E4] no scoring system was used. 
Another possible xplanation for the lower mortal- 
ity found in our study is that in l l  of our 31 ventilated 
patients, there were no incidents respiratory failure 
according to the previously described criteria used in 
this study. The mortality in this group of ventilated 
patients was 45% (5/11) as compared to a mortality of 
60% (12/20) in the group with respiratory failure. In the 
other studies there are no data on this, but it is possible 
that our patients were ventilated in an earlier stage. 
The difference in mortality rates is probably be due 
to differences in admission policies. In the period of this 
study, 48 oncologic patients died in our hospital in 
wards other than the PICU. In 25 of these patients 
(52%), a NTBR policy was used, because of their poor 
oncologic prognosis. One hundred-eighteen patients 
died at home and most of them after a palliative treat- 
ment. An explanation for the difference in mortality 
could therefore be, that in the other studies more end- 
stage patients were admitted to the PICU. 
We conclude that children with cancer have a high 
risk of dying when they reach the stage that admission 
to the PICU is necessary. The PRISM scoring system 
is not applicable to this group of patients, therefore 
a mortality risk cannot be predicted. Mortality rises 
when the number of interventions such as mechanical 
ventilation or inotropic support rises, or when com- 
plications such as neutropenia or septic shock are 
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involved. The quest ion,  therefore, rises whether  ear ly 
P ICU admiss ion  would  favorab ly  affect the outcome.  
In our  hospi ta l  there is a close cooperat ion  between 
pediatr ic  onco logy  and intensive care teams. Good 
communicat ion  is necessary to decide whether  a pa- 
t ient should be admi t ted  to the P ICU.  The decis ion to 
cont inue t reatment  should  not  be everlast ing; recons id-  
erat ion has to take place with every major  change in 
therapy  or the cond i t ion  of the pat ient.  
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